CCI gives nod to Fortis group, Sun Pharma deals
The Competition Commission of India has approved the multi-layered reorganisation involving Fortis group companies. Under the deal, Fortis will be carrying out the rejig that involves three entities, Fortis Healthcare, Fortis Malar Hospitals, and SRL Ltd. Besides, the watchdog also cleared RPG Life Sciences’ acquisition of assets of Sun Pharmaceutical Industries and Sun Pharma Laboratories.